By 2030, it is projected that diabetes will affect approximately 439 million people worldwide, with developing countries experiencing the highest rates of increase (In 2010, developing countries accounted for 69% of the total cases, while developed nations accounted for 20%) (1)
while rare (currently said to be less than 3%), I would hate to induce an antibody formation and essentially waste the chance of re-initiating a GLP-1 RA should they gain weight back
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets
Latin America 7.5.1
Also, natural retailers dont typically chase trends, especially those centered around prescription drugs
BMJ Open 9:e024954 Soliman GF, Hashem G, Fawzy MG, Ibrahim W (2019) Neuroprotective effects of metformin versus selegiline on parkinsons disease model by reserpine through the interrelation of synuclein and antioxidants on behavioral changes in rats